Please assess the completion status of the following clinical trial:

Trial Title: Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Newly diagnosed adult cancer patients from VICC and MMC~* Caregiver of enrolled newly diagnosed adult cancer patients from VICC and MMC~* No prior history of malignancy other than non-melanoma skin cancer~* Planned treatment for stages I - III cancer~* Treatment expected to be completed within 12 months~* English speaking~Exclusion Criteria:~* Prior history of malignancy other than non-melanoma skin cancer~* Patients treated with surgery alone will not be included~* Patients whose treatment is expected to last more than 12 months~* Non-English speaking

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- NEST Intervention (Type: EXPERIMENTAL): Patients (PTs) and their caregivers (CGs) receive educational intervention, follow-up care, psychosocial assessment and care, and questionnaire administration interventions by completing psychosocial questionnaires and meeting with a nurse practitioner (NP) or nurse navigator (NN) for an initial survivorship care planning session to review the expected course of therapy and recovery, identify resources that may be needed and provide recommendations for follow-up. At the end of their treatment EOT), PTs and their CGs complete a 2nd set of questionnaires and meet with the NP/NN for a booster survivorship care planning session. They will receive an individualized final survivorship care plan and related materials. 2 months after EOT, PTs and their CGs complete a final set of questionnaires.

Based on this trial design, predict the completion outcome and termination type (if applicable).